Trials / Recruiting
RecruitingNCT07210190
Microneedling for Skin Heath
A Prospective Clinical Study Evaluating the Effects of a Topical Multivitamin Serum, Containing PDRN on Facial Skin Hydration and Biophysical Parameters Following Microneedling
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Erevna Innovations Inc. · Academic / Other
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Skin boosters are treatments designed to improve skin quality and restore skin health. Some of these treatments are based on polynucleotides, which are small fragments of DNA. One such compound, called Polydeoxyribonucleotide (PDRN), is obtained from fish sources such as salmon or trout. PDRN has shown regenerative and anti-inflammatory properties, and in medical practice it has been used to support wound healing, scar improvement, and skin rejuvenation by helping with elasticity, texture, and fine lines. VAMP™ Multivitamin Serum is a topical formulation that contains PDRN along with amino acids, vitamins, and peptides. It is designed to improve hydration, elasticity, and overall skin radiance. While early data suggest potential benefits, clinical research is still limited, and further study is needed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microneedeling with topical application of VAMP™ Topical Multivitamin Serum | VAMP™ Topical Multivitamin Serum is not indicated for use in pregnancy, lactation, or in individuals under the age of 22. Female participants of childbearing potential will be required to undergo urine pregnancy testing at baseline and prior to each treatment session. They will also be instructed to use an acceptable form of effective contraception for the duration of the study. |
Timeline
- Start date
- 2026-01-17
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-10-07
- Last updated
- 2026-02-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07210190. Inclusion in this directory is not an endorsement.